Article Versions Notes

Mishchenko M, Shtrygol’ S, Lozynskyi A, Hoidyk M, Khyluk D, Gorbach T, Lesyk R. Evaluation of 5-[(Z)-(4-nitrobenzylidene)]-2-(thiazol-2-ylimino)-4-thiazolidinone (Les-6222) as Potential Anticonvulsant Agent. Scientia Pharmaceutica. 2022; 90(3):56. https://doi.org/10.3390/scipharm90030056

Mishchenko, Mariia, Sergiy Shtrygol’, Andrii Lozynskyi, Mykhailo Hoidyk, Dmytro Khyluk, Tatyana Gorbach, and Roman Lesyk. 2022. "Evaluation of 5-[(Z)-(4-nitrobenzylidene)]-2-(thiazol-2-ylimino)-4-thiazolidinone (Les-6222) as Potential Anticonvulsant Agent" Scientia Pharmaceutica 90, no. 3: 56. https://doi.org/10.3390/scipharm90030056

Mishchenko, M., Shtrygol’, S., Lozynskyi, A., Hoidyk, M., Khyluk, D., Gorbach, T., & Lesyk, R. (2022). Evaluation of 5-[(Z)-(4-nitrobenzylidene)]-2-(thiazol-2-ylimino)-4-thiazolidinone (Les-6222) as Potential Anticonvulsant Agent. Scientia Pharmaceutica, 90(3), 56. https://doi.org/10.3390/scipharm90030056